Ninlaro 4 MG capsule 3S
Ended Awarded Last action
- Contract number
- SPE2DR26F9LG9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,929
Award facts
- Contract value 100% obligated
- $17,928.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $17,928.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 15, 2026, for the supply of Ninlaro 4 mg capsules. This contract is a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999.999 billion through December 2026), which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The award was made on a competitive basis with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of February 6, 2026. Ninlaro is a specialty oncology medication used in cancer treatment, reflecting the strategic pharmaceutical supply chain support that DLA maintains for military treatment facilities and veterans' healthcare systems.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor and critical federal vendor specializing in brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The company's extensive federal contract portfolio demonstrates its capability to fulfill complex medical procurement requirements across multiple therapeutic domains. As a prime vendor under DLA's pharmaceutical support program, AmerisourceBergen serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, positioning it as a key supplier in the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F9LG9?
SPE2DR26F9LG9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26F9LG9 worth?
The government has obligated $17,929 on SPE2DR26F9LG9.
Is contract SPE2DR26F9LG9 an order under another contract?
Yes. SPE2DR26F9LG9 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9LG9 competed?
The extent of competition for SPE2DR26F9LG9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award